We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+3.86%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$18.8B
AUM Growth
+$1.08B
Cap. Flow
+$375M
Cap. Flow %
1.99%
Top 10 Hldgs %
32.3%
Holding
1,384
New
65
Increased
662
Reduced
357
Closed
63

Top Buys

Rank Stock Value
1
CCI icon
Crown Castle
CCI
+$243M
2
PLD icon
Prologis
PLD
+$106M
3
DLR icon
Digital Realty Trust
DLR
+$97.4M
4
KIM icon
Kimco Realty
KIM
+$96.3M
5
SNOW icon
Snowflake
SNOW
+$88.7M

Top Sells

Rank Stock Value
1
O icon
Realty Income
O
+$225M
2
INVH icon
Invitation Homes
INVH
+$153M
3
EQIX icon
Equinix
EQIX
+$91.3M
4
SPG icon
Simon Property Group
SPG
+$91.1M
5
AMT icon
American Tower
AMT
+$91M

Sector Composition

Rank Sector Weight
1 Real Estate 42.05%
2 Technology 19.13%
3 Communication Services 6.55%
4 Consumer Discretionary 6.17%
5 Financials 5.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRUS
1126
DELISTED
Merus
MRUS
$15K ﹤0.01%
251
+65
+35% +$3.15K
AXSM icon
1127
Axsome Therapeutics
AXSM
$12.3B
$14K ﹤0.01%
175
– –
CLPR
1128
Clipper Realty
CLPR
$46.4M
$14K ﹤0.01%
3,778
– –
IMVT icon
1129
Immunovant
IMVT
$8.23B
$14K ﹤0.01%
537
– –
OUT icon
1130
Outfront Media
OUT
$5.68B
$14K ﹤0.01%
964
-106
-10% -$1.55K
XLK icon
1131
State Street Technology Select Sector SPDR ETF
XLK
$114B
$14K ﹤0.01%
+122
New +$12.8K
DNLI icon
1132
Denali Therapeutics
DNLI
$3.74B
$13K ﹤0.01%
546
– –
DYN icon
1133
Dyne Therapeutics
DYN
$4.24B
$13K ﹤0.01%
371
+71
+24% +$2.06K
CRNX icon
1134
Crinetics Pharmaceuticals
CRNX
$8.87B
$12K ﹤0.01%
273
– –
GH icon
1135
Guardant Health
GH
$19.3B
$12K ﹤0.01%
412
– –
RARE icon
1136
Ultragenyx Pharmaceutical
RARE
$2.65B
$12K ﹤0.01%
304
– –
SHY icon
1137
iShares 1-3 Year Treasury Bond ETF
SHY
$25.4B
$12K ﹤0.01%
+145
New +$11.8K
ARWR icon
1138
Arrowhead Research
ARWR
$12B
$11K ﹤0.01%
426
– –
FOLD
1139
DELISTED
Amicus Therapeutics
FOLD
$11K ﹤0.01%
1,130
– –
ACLX
1140
DELISTED
Arcellx
ACLX
$10K ﹤0.01%
176
– –
BMO icon
1141
Bank of Montreal
BMO
$125B
$10K ﹤0.01%
120
– –
GERN icon
1142
Geron
GERN
$949M
$10K ﹤0.01%
2,247
+840
+60% +$3.27K
TWST icon
1143
Twist Bioscience
TWST
$5.39B
$10K ﹤0.01%
210
– –
XENE icon
1144
Xenon Pharmaceuticals
XENE
$6.36B
$10K ﹤0.01%
252
– –
ACAD icon
1145
Acadia Pharmaceuticals
ACAD
$4.35B
$9K ﹤0.01%
551
-100
-15% -$1.61K
ADMA icon
1146
ADMA Biologics
ADMA
$1.97B
$9K ﹤0.01%
791
– –
AGIO icon
1147
Agios Pharmaceuticals
AGIO
$2.2B
$9K ﹤0.01%
204
– –
AHT
1148
Ashford Hospitality Trust
AHT
$20.9M
$9K ﹤0.01%
920
– –
PTCT icon
1149
PTC Therapeutics
PTCT
$6.29B
$9K ﹤0.01%
289
– –
RYTM icon
1150
Rhythm Pharmaceuticals
RYTM
$7.28B
$9K ﹤0.01%
227
– –
44 45
46
47 48

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q2 2024 Portfolio in Review

As of Q2 2024, Daiwa Securities Group held 1,384 positions worth $18.8B, up 6.1% from $17.7B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Daiwa Securities Group's Q2 2024 filing shows 65 new, 662 increased, 357 reduced and 63 closed positions. Its largest new stake was NextEra Energy 7.299% Corporate Units: 500,000 shares worth $24.6M. The largest sale was Realty Income, an estimated $225M.

By sector, the portfolio is most concentrated in Real Estate at 42% of assets, down from 46% a quarter earlier, followed by Technology and Communication Services.

  • Daiwa Securities Group's largest Q2 2024 buy was NextEra Energy 7.299% Corporate Units: 500,000 shares worth $24.6M.
  • Daiwa Securities Group added most to Crown Castle in Q2 2024, an estimated $243M increase.
  • Daiwa Securities Group's biggest Q2 2024 reduction was Realty Income, cutting an estimated $225M.
  • Daiwa Securities Group fully exited Apartment Income REIT Corp. in Q2 2024, selling an estimated $88.4M.
  • Daiwa Securities Group's ten largest holdings make up 32% of its $18.8B portfolio in Q2 2024.
  • Daiwa Securities Group opened 65 new positions and closed 63 in Q2 2024.
  • Daiwa Securities Group's portfolio value rose 6.1% quarter-over-quarter to $18.8B.

Based on Daiwa Securities Group's 13F filing for Q2 2024, filed 7 Aug 2024.